Investing

Haemonetics receives FDA clearance for plasma collection system

BOSTON - Haemonetics Corporation (NYSE:HAE) announced today it received U.S. Food and Drug Administration 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS technology, ...
英为财情

血液技术公司Haemonetics获FDA批准推出血浆采集系统

波士顿 - Haemonetics Corporation (NYSE:HAE)今日宣布,其配备Persona PLUS技术的NexSys PCS血浆采集系统已获得美国食品药品监督管理局510(k)许可,公司新闻稿称。据InvestingPro分析,这家市值28.4亿美元的医疗技术公司财务健康评分为"优秀"。 该许可获批得益于一项前瞻性、随机 ...
BioSpace

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona ...

BOSTON, Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...
Malaysian Reserve

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona ...

BOSTON, Feb. 23, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...
MassDevice

Haemonetics gets FDA nod for next-gen plasma collection system

The NexSys PCS system. [Image courtesy of Haemonetics] Haemonetics (NYSE: HAE) + announced that it received FDA approval for its NexSys PCS plasma collection system with Persona PLUS technology.
MarketWatch

Haemonetics Gets FDA Clearance for Next-Gen Plasma Collection System

Haemonetics received clearance from the Food and Drug Administration for its next-generation plasma collection system. The medical technology company said Monday that the FDA granted 510(k) clearance ...